// App-Quantinova.ai

614 : Effect of Tofacitinib on Reducing Pain in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

Researchers

Presenter

  • Alexis Ogdie

Principal Investigators

  • Kurt de Vlam

  • Iain B. McInnes

  • Philip J Mease

  • Philip Baer

  • Tatjana Lukic

  • Kenneth Kwok

  • Cunshan Wang

  • Ming-Ann Hsu

  • Anna Maniccia

Medical Centers

  • Division of Hematology and Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA

  • KU Leuven, Leuven, Belgium

  • Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom

  • Swedish Medical Center and University of Washington School of Medicine, Seattle, WA

  • Baer Weinberg MPC, Scarborough, ON, Canada

  • Pfizer Inc, New York, NY

  • Pfizer, Groton, CT

Locations

  • United States

  • Belgium

  • United Kingdom

  • Canada

Companies

  • Pfizer Inc.

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • Cluster of differentiation 95

Drug/Treatment

  • Tasocitinib

Outcome

  • N/A

Study Design

  • Placebo Control

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved